Novel oral anticoagulants work as well as warfarin

Clinical trials have shown that novel oral anticoagulants (NOACs) are as efficacious as warfarin in reducing the risk of stroke in patients with atrial fibrillation, reports the MJA. Notwithstanding, the reaserchers say that concerns remain regarding the efficacy of NOACs in real life situations, given the study looked at patients older than 75 with other